© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
September 08, 2020
The majority of orphan drugs are subject to utilization controls in Medicare Part D plans. The use of utilization controls varies by certain drug characteristics.
July 19, 2013
Without clinical information, a decrease in use of medications can serve as a proxy for clinical improvement.
November 20, 2012
The aDCSI without the inclusion of laboratory data performs similarly to the DCSI with laboratory results, and is a good measure of diabetes severity.
April 23, 2012
The Diabetes Complications Severity Index without laboratory test results is a good measure of diabetes severity, given its ability to explain costs.